VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

11012	Companies
241252	Keywords
169796	Articles
129860	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 01/09/2026 at 07:00, 8 months 8 days ago

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Valneva SE to meet with investors at the J.P. Morgan Healthcare Conference to discuss upcoming catalysts from its clinical development pipeline and commercial portfolio of vaccines. Company specializes in prophylactic vaccines for infectious diseases

Valneva SE Prophylactic Vaccines J.P. Morgan Healthcare Conference Vaccine Company Clinical Development Pipeline
BRIEF

published on 12/31/2025 at 17:50, 8 months 16 days ago

Valneva and Serum Institute End Chikungunya Vaccine Collaboration

Public Health Valneva License Agreement Chikungunya Vaccine Serum Institute
PRESS RELEASE

published on 12/31/2025 at 17:45, 8 months 16 days ago

Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Valneva and Serum Institute of India mutually agree to discontinue chikungunya vaccine license. Valneva aims for direct control over supply chain and access to high-risk regions

Valneva License Agreement CEPI Chikungunya Vaccine Serum Institute Of India
BRIEF

published on 12/10/2025 at 17:50, 9 months 6 days ago

Valneva obtains positive results in Phase 2 for the chikungunya vaccine in children

Valneva Safety Vaccine Phase 2 Chikungunya
BRIEF

published on 12/10/2025 at 17:50, 9 months 6 days ago

Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children

Valneva SE Phase 2 Study Children's Health Chikungunya Vaccine Vaccine Safety
PRESS RELEASE

published on 12/10/2025 at 17:45, 9 months 6 days ago

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Valneva reports positive final phase 2 antibody persistence and safety results for children with its Chikungunya vaccine IXCHIQ®. Twelve-month data supports full dose selection for Phase 3 trial

Phase 3 Trial Valneva Vaccine Chikungunya Antibody Persistence
BRIEF

published on 12/05/2025 at 18:39, 9 months 11 days ago

Valneva Updates Share and Voting Rights as of November 2025

Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
BRIEF

published on 12/05/2025 at 18:39, 9 months 11 days ago

VALNEVA: Declaration of Shares and Voting Rights

Euronext Paris Voting Rights Ordinary Shares Valneva 2025
PRESS RELEASE

published on 12/05/2025 at 18:34, 9 months 11 days ago

VALNEVA Declaration of shares and voting rights: November 30, 2025
VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form

Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF

published on 12/03/2025 at 11:03, 9 months 14 days ago

Valneva SE: Promising Developments in Lyme Disease Vaccine

Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15

Accesswire

Published on 09/17/2026 at 12:00, 51 minutes ago

Banyan Gold Intersects 1.05 g/t Gold over 52.8 metres and Bonanza-Grade Gold at Powerline Deposit, AurMac, Yukon, Canada
Published on 09/17/2026 at 10:00, 2 hours 51 minutes ago

Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 13 hours 6 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 15 hours 21 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 19 hours 56 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 12:29, 22 minutes ago

Electricity cloud market in transition: What options do customers have now?
Published on 09/17/2026 at 12:28, 23 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 09/17/2026 at 12:22, 29 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 09/17/2026 at 12:15, 36 minutes ago

BDStar Hosted 2026 Ecosystem Partner Conference in Munich, Germany
Published on 09/17/2026 at 12:01, 50 minutes ago

Alina Holdings PLC: 2026 Interim Results

Les Echos

Published on 09/16/2026 at 20:46, 16 hours 5 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 19 hours 6 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 19 hours 6 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 5 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 18 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE